Boehringer, U.K. groups partner for CF gene therapy

Boehringer Ingelheim GmbH (Ingelheim, Germany) will collaborate with several U.K. universities and companies to develop a gene

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE